Niagen Bioscience (NAGE) Inventory (2011 - 2026)
Niagen Bioscience (NAGE) posted quarterly Inventory of $24.0 million for Q1 2026, up 114.72% year-over-year from $11.2 million in Q1 2025, and up 17.59% quarter-over-quarter from $20.4 million in Q4 2025.
Niagen Bioscience (NAGE) Inventory (2011 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Inventory for 14 consecutive years, with $24.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 114.72% year-over-year to $24.0 million; the TTM figure through Mar 2026 stood at $24.0 million (up 114.72% YoY), while the FY2025 annual figure was $20.4 million, up 122.19% from the prior year.
- Inventory rose to $24.0 million in Q1 2026 per NAGE's latest filing, from $20.4 million in the prior quarter.
- Across five years, Inventory topped out at $24.0 million in Q1 2026 and bottomed at $9.2 million in Q4 2024.
- Historically, Inventory has averaged $14.4 million across 5 years, with a median of $14.4 million in 2025.
- Annual changes were most pronounced in 2024 — Inventory sank 36.72% — and 2025, when it soared 122.19%.
- Niagen Bioscience's Inventory stood at $14.7 million in 2022, then fell by 1.04% to $14.5 million in 2023, then tumbled by 36.72% to $9.2 million in 2024, then soared by 122.19% to $20.4 million in 2025, then increased by 17.59% to $24.0 million in 2026.
- Business Quant data shows NAGE's Inventory at $24.0 million in Q1 2026, $20.4 million in Q4 2025, and $18.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 371.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 732.60 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 358,916.96 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 97.11 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 20.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.64 Mn |
| Mar 31, 2026 | 24.02 Mn |
| Dec 31, 2025 | 20.42 Mn |
| Sep 30, 2025 | 18.79 Mn |
| Jun 30, 2025 | 14.41 Mn |
| Mar 31, 2025 | 11.19 Mn |
| Dec 31, 2024 | 9.19 Mn |
| Sep 30, 2024 | 10.54 Mn |
| Jun 30, 2024 | 11.51 Mn |
| Mar 31, 2024 | 12.50 Mn |
| Dec 31, 2023 | 14.53 Mn |
| Sep 30, 2023 | 12.62 Mn |
| Jun 30, 2023 | 11.97 Mn |
| Mar 31, 2023 | 11.91 Mn |
| Dec 31, 2022 | 14.68 Mn |
| Sep 30, 2022 | 15.64 Mn |
| Jun 30, 2022 | 15.75 Mn |
| Mar 31, 2022 | 15.31 Mn |
| Dec 31, 2021 | 13.60 Mn |
| Sep 30, 2021 | 12.68 Mn |